𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Liver transplantation in human immunodeficiency virus-positive patients

✍ Scribed by Deepak Joshi; John O'Grady; Chris Taylor; Nigel Heaton; Kosh Agarwal


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
138 KB
Volume
17
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis


With the successful introduction of combined antiretroviral therapy (cART), human immunodeficiency virus (HIV) is now regarded as a chronic illness with excellent long-term outcomes. However, chronic exposure to viral etiologies (ie, chronic hepatitis B and hepatitis C) and drug-induced toxicity secondary to cART have resulted in increasing rates of mortality and morbidity due to end-stage liver disease. HIV disease is no longer considered an absolute contraindication to liver transplantation (LT) by most transplant centers worldwide. Because the burden of liver disease in this cohort is likely to increase, this review addresses the key etiologies and the management strategies available for HIV-positive patients undergoing LT.


πŸ“œ SIMILAR VOLUMES


Orthotopic liver transplantation in huma
✍ Martin Vogel; Esther Voigt; Nico SchΓ€fer; Georg Goldmann; Nicolas Schwarz; JΓΆrg πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 117 KB

The outcome and clinical features of 7 HIV-positive patients who were liver transplanted at Bonn University in the era of highly active antiretroviral therapy (HAART) between 1997 and 2004, analyzed by retrospective chart review, are reported. Reasons for orthotopic liver transplantation (OLT) were

Liver transplantation in human immunodef
✍ P. Thomas Cherian; Wesal Alrabih; Abdel Douiri; Alberto Quaglia; Michael A. Hene πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 111 KB

Liver transplantation (LT) for human immunodeficiency virus (HIV)-positive recipients with end-stage liver disease has become an accepted practice. However, because these patients are increasingly being recognized as prothrombotic, we reviewed their posttransplant thrombotic complications. Because m

A new indication for liver transplantati
✍ Mariagrazia Tateo; MylΓ¨ne Sebagh; Marie-Pierre Bralet; Elina Teicher; Daniel Azo πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 219 KB

Nodular regenerative hyperplasia is one of the causes of noncirrhotic portal hypertension and has recently been described in human immunodeficiency virus-infected patients, and the potential role of a prothrombotic state and hepatotoxic antiretroviral medication has been suggested. Moreover, it is n

Transmission of human immunodeficiency v
✍ Joseph Ahn; Stanley M. Cohen πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 84 KB

In November 2007, a liver transplant recipient was confirmed to have human immunodeficiency virus (HIV) and hepatitis C (HCV) infection after the organ procurement agency notified our institution that the donor has been HIV and HCV positive. We reviewed medical records and the collected blood sample

Transmission of human immunodeficiency v
✍ Michael G. Ison; John J. Friedewald πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 38 KB πŸ‘ 1 views

We are writing in regard to a recently published article by Ahn and Cohen documenting the transmission of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) to a liver recipient, 2 kidney recipients, and 1 heart recipient. 1 The authors clearly present the case from their patients' persp